Your Wellbeing International Foundation

A closer look at the investment history linked to a modern regenerative therapy venture By Steven Millard | Investigations Desk Regenerative medicine is often presented as the future of healthcare — a world of innovation, research, and scientific possibility. Yet behind the language of progress sits a financial landscape that many prospective clients may never fully explore. An examination of corporate records connected to investor  Max Robert Lewinsohn , a senior financial figure associated with Wellbeing International Foundation , reveals a business career rooted in high-risk investment ventures rather than clinical medicine. Across several decades, some of those ventures have ended in administration, liquidation, or legal dispute. While none of these events relate directly to medical procedures, they raise broader questions about transparency when significant private investment intersects with healthcare-adjacent industries. FROM BALANCE SHEETS TO BIOLOGY Lewinsohn’s profession...

THE HOPE MERCHANTS Inside the booming stem-cell “miracle” industry — and the patients left paying the price It always starts the same way. A bad knee that never heals. A parent frightened for their child. A tremor that could become something worse. A diagnosis that steals your future one appointment at a time. Somewhere between fear and fatigue, a new promise appears:  regenerative medicine .  Stem cells .  Exosomes .  Secretomes . Words that sound like the frontier of science — and are often used like a sales script. In the legitimate world, cell therapies take years of trials, mountains of data, and strict regulatory approvals. In the shadow industry, hope is packaged like a luxury product: a consultation that feels like certainty, a checkout that feels like salvation. And the bill can land anywhere between “a few grand” and the kind of money that changes a life. This industry has become a  global marketplace of aspiration  — and, regulators warn, it has ...

  Inside the private medical company accused of exploiting science, loopholes and vulnerable patients For years,  Wellbeing International Foundation Ltd  (WIF) has marketed itself as a pioneer of cutting-edge regenerative medicine — promising relief from chronic pain, repair of damaged tissue, and even protection against serious disease. But an investigation drawing on undercover recordings, expert scientific analysis, and legal opinion paints a very different picture: one of extraordinary medical claims, minimal oversight, and sales practices that critics say cross the line from innovation into deception. At the centre of the controversy are high-priced treatments — often costing tens of thousands of pounds or dollars — sold remotely, without medical consultation, and promoted using complex biological language that independent experts say is unsupported by clinical evidence. The business of belief WIF presents its therapies as a sophisticated alternative to traditional s...

An undercover recording has raised serious questions about how a high-priced regenerative treatment was marketed to a prospective patient — entirely by phone, without a medical consultation, and by a salesperson who is not a doctor. The recording, obtained during an independent investigation, captures a telephone conversation between an undercover operative based in the United States and Andrew Chancellor, a representative of Wellbeing International Foundation Ltd. Over the course of the call, Chancellor promotes a proposed treatment costing  $48,000 , outlines how it would be delivered, and makes a series of medical claims — despite not holding medical qualifications. No physical examination takes place. No medical records are reviewed. At no point is the patient advised to consult their own doctor. Instead, the discussion moves rapidly from symptoms to solution — and then to payment. No consultation, no treating doctor According to the recording, the entire interaction takes plac...

  FALSE HOPE – AN INVESTIGATION INTO THE SELLING OF BOGUS STEM CELL TREATMENTS Sitting in a smart office on London’s prestigious Harley Street, the patient explains to Dr. Stephen Ray his long list of ailments: a melanoma scar, chronic sports injuries, and diabetes.  The man, desperately seeking answers, listens intently as Ray spins an enticing tale of cutting-edge science. “Our treatment is revolutionary,” he says, leaning in for effect. “It’s not just about fixing what’s wrong—it’s about protecting you from future damage too.” Dr Ray explains his company, Wellbeing International Foundation Ltd (WIFL), use secretions from stem cells called extracellular vesicles (EVs) to heal the body. “We take your blood, send it to our labs in Germany, and put the cells under controlled stress to produce these miraculous EVs,” he says, his tone calm and confident. The price for the cure? £37,000. Dr Ray also claims his company can prevent life-threatening diseases.  “If you think o...